These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 2160059)

  • 21. Inhibition of herpes simplex virus types 1 and 2 replication in vitro by mercurithio analogs of deoxyuridine.
    Holliday J; Williams MV
    Antiviral Res; 1991 Sep; 16(2):197-203. PubMed ID: 1665962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2'-Fluorinated arabinonucleosides of 5-(2-haloalkyl)uracil: synthesis and antiviral activity.
    Griengl H; Wanek E; Schwarz W; Streicher W; Rosenwirth B; De Clercq E
    J Med Chem; 1987 Jul; 30(7):1199-204. PubMed ID: 3037079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incorporation of E-5-(2-halovinyl)-2'-deoxyuridines into deoxyribonucleic acids of herpes simplex virus type 1-infected cells.
    Allaudeen HS; Chen MS; Lee JJ; De Clercq E; Prusoff WH
    J Biol Chem; 1982 Jan; 257(2):603-6. PubMed ID: 6274855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of distamycin A on some biochemical functions of tissue cultures infected with Herpes simplex virus.
    Verini MA; D'amico G; Sanfilippo A; Arcamone F
    Farmaco Sci; 1976 Oct; 31(10):705-13. PubMed ID: 188685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral activity of the 3'-amino derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    De Clercq E; Descamps J; Balzarini J; Fukui T; Allaudeen HS
    Biochem J; 1983 May; 211(2):439-45. PubMed ID: 6307280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiherpes virus activity and effect on deoxyribonucleoside triphosphate pools of (E)-5-(2-bromovinyl)-2'-deoxycytidine in combination with deaminase inhibitors.
    Aduma PJ; Gupta SV; De Clercq E
    Antiviral Res; 1990 Mar; 13(3):111-25. PubMed ID: 2162147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of viral ribonucleotide reductase in the increase of dTTP pool size in herpes simplex virus-infected Vero cells.
    Daikoku T; Yamamoto N; Maeno K; Nishiyama Y
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1441-4. PubMed ID: 1646284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incorporation and metabolism of 2'-fluoro-5-substituted arabinosyl pyrimidines and their selective inhibition of viral DNA synthesis in herpes simplex virus type 1 (HSV-1)-infected and mock-infected Vero cells.
    Kong XB; Scheck AC; Price RW; Vidal PM; Fanucchi MP; Watanabe KA; Fox JJ; Chou TC
    Antiviral Res; 1988 Dec; 10(4-5):153-66. PubMed ID: 2852483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy of banal HSV lesions: molecular mechanisms of the antiviral activity of zinc sulfate].
    Kümel G; Schrader S; Zentgraf H; Brendel M
    Hautarzt; 1991 Jul; 42(7):439-45. PubMed ID: 1657829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of multiplication of herpes simplex virus by caffeic acid.
    Ikeda K; Tsujimoto K; Uozaki M; Nishide M; Suzuki Y; Koyama AH; Yamasaki H
    Int J Mol Med; 2011 Oct; 28(4):595-8. PubMed ID: 21725588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.
    Field AK; Davies ME; DeWitt C; Perry HC; Liou R; Germershausen J; Karkas JD; Ashton WT; Johnston DB; Tolman RL
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4139-43. PubMed ID: 6306664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism of the carbocyclic analogue of (E)-5-(2-iodovinyl)-2'-deoxyuridine in herpes simplex virus-infected cells. Incorporation of C-IVDU into DNA.
    De Clercq E; Bernaerts R; Balzarini J; Herdewijn P; Verbruggen A
    J Biol Chem; 1985 Sep; 260(19):10621-8. PubMed ID: 2993282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiherpes activity of [E]-5-(1-propenyl)-2'-deoxyuridine and 5-(1-propenyl)-1-beta-D-arabinofuranosyluracil.
    Stening G; Gotthammar B; Larsson A; Alenius S; Johansson NG; Oberg B
    Antiviral Res; 1981 Nov; 1(4):213-23. PubMed ID: 6280606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-Substituted 2'-deoxyuridines which selectively inhibit herpes simplex virus replication.
    De Clercq E
    Adv Ophthalmol; 1979; 38():204-13. PubMed ID: 230717
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies to show that with podophyllotoxin the early replicative stages of herpes simplex virus type 1 depend upon functional cytoplasmic microtubules.
    Hammonds TR; Denyer SP; Jackson DE; Irving WL
    J Med Microbiol; 1996 Sep; 45(3):167-72. PubMed ID: 8810942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The structure and function of the HSV DNA replication proteins: defining novel antiviral targets.
    Matthews JT; Terry BJ; Field AK
    Antiviral Res; 1993 Feb; 20(2):89-114. PubMed ID: 8384825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of (E)-5-(3,3,3-trifluoro-1-propenyl)-2'-deoxyuridine and related analogues: potent and unusually selective antiviral activity of (E)-5-(3,3,3-trifluoro-1-propenyl)-2'-deoxyuridine against herpes simplex virus type 1.
    Bergstrom DE; Ruth JL; Reddy PA; De Clercq E
    J Med Chem; 1984 Mar; 27(3):279-84. PubMed ID: 6321735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism and mode of action of (R)-9-(3,4-dihydroxybutyl)guanine in herpes simplex virus-infected vero cells.
    Stenberg K; Larsson A; Datema R
    J Biol Chem; 1986 Feb; 261(5):2134-9. PubMed ID: 2418021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incorporation of carbocyclic (E)-5-(2-iodovinyl)-2'-deoxyuridine (C-IVDU) into DNA of herpes simplex virus-infected cells.
    Bernaerts R; De Clercq E; Balzarini J; Herdewijn P; Verbruggen A
    Antiviral Res; 1985; Suppl 1():51-6. PubMed ID: 3002266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-(2-Chloroethyl)-2'-deoxyuridine: a potent and selective inhibitor of herpes viruses in vitro and in vivo.
    Rosenwirth B; Griengl H; Wanek E; De Clercq E
    Antiviral Res; 1985; Suppl 1():20-8. PubMed ID: 3002256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.